,
,
,
, djouadi@inserm.fr Supported by a grant
, Carnitine pal
, mi toyltransferase II deficiency: a clinical, biochemical, and molecular review, Lab Invest, vol.83, pp.1543-54, 2003.
, Correlation between 2. genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 deficiency, Tenenbaum A, Motro M, Fisman EZ. Dual and pan-peroxi, vol.21, pp.493-501, 2003.
, some proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons, Cardiovasc Diabetol, vol.4, p.14, 2005.
, J Clin Endocrinol Metab, vol.90, pp.1791-1798, 2005.
, Please note the following: ?Letters in reference to a Journal article must not exceed 175 words (excluding references) and must be received within 3 weeks after publication of the article. Letters not related to a Journal article must not exceed 400 words. All letters must be submitted over the Internet at authors.NEJM.org. ?A letter can have no more than five references and one figure or table
, Such disclosures will be published with the letters. For authors of Journal articles who are responding to letters, this information appears in the published articles.) ?Include your full mailing address, telephone number, fax number, and e-mail address with your letter, ?Financial associations or other possible conflicts of interest must be disclosed
, We cannot acknowledge receipt of your letter, but we will notify you when we have made a decision about publication. Letters that do not adhere to these instructions will not be considered. Rejected letters and figures will not be returned. We are unable to provide prepublication proofs. Submission of a letter constitutes permission for the Massachusetts Medical Society, its licensees, and its assignees to use it in the Journal's various print and electronic publications and in collections, revisions, and any other form or medium